Frontier Biotechnologies (688221.SS) Stock Price
Frontier Biotechnologies Price
Over the last 7 years Frontier Biotechnologies grew revenue by 81.4% annually, reaching 123.39 M CNY. For Frontier Biotechnologies, the net margin of -217.2% is up versus -642.1% a few years ago. The consensus 12-month price target for Frontier Biotechnologies is 16.12 CNY, about 7.5% above where the stock trades today. Of 7 analysts, 5 rate the stock a buy — an overall Buy consensus.
Frontier Biotechnologies stock price
Frontier Biotechnologies business model & stock analysis
Frequently asked questions about Frontier Biotechnologies
Analysts currently set an average price target of 16.12 CNY for the Frontier Biotechnologies stock (median: 16.12 CNY), implying +7.5 % versus the latest price. The consensus is based on 7 analyst ratings.
5 analysts currently rate the Frontier Biotechnologies stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Frontier Biotechnologies to generate revenue of 449.00 M CNY and earnings per share of 0.02 CNY.
Converted at the current exchange rate, the Frontier Biotechnologies share trades at 2.00 EUR (14.99 CNY).
The expected revenue of Frontier Biotechnologies is 449.00 M CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Frontier Biotechnologies is 7.49 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Frontier Biotechnologies is currently 749.50. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Frontier Biotechnologies stock.
The price-to-sales ratio (P/S) of Frontier Biotechnologies is currently 12.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Frontier Biotechnologies stock.
The Eulerpool Quality Score for Frontier Biotechnologies is 3/10.
The ISIN of Frontier Biotechnologies is CNE100005XF5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Frontier Biotechnologies is 688221.SS. The ticker symbol is used to trade Frontier Biotechnologies shares on the stock exchange.
Frontier Biotechnologies stock
Frontier Biotechnologies Peer Group
Frontier Biotechnologies FIGI
All fundamentals and in-depth analysis of Frontier Biotechnologies
Our stock analysis for Frontier Biotechnologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Frontier Biotechnologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.